Meropenem-0.9% nacl 1 gram/50S
Ended Awarded
- Contract number
- SPE2DR26FCM8S
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,869
Award facts
- Contract value 100% obligated
- $3,869.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $3,869.42 to AmerisourceBergen Drug Corp for the supply of Meropenem 0.9% Sodium Chloride (1 gram/50s) with an ultimate completion date of November 6, 2025. This competitively awarded, firm fixed price contract contains no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a total contract value of $999,999,999.00 through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that supplies a comprehensive range of medical products to federal customers, particularly the Defense Health Agency, U.S. Coast Guard, and military healthcare systems. The company maintains an extensive portfolio of federal contract awards with the Defense Logistics Agency Medical Supply Chain, covering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. The SPE2DX prime IDC enables flexible fulfillment of critical medical supply needs across multiple therapeutic domains, positioning AmerisourceBergen as a key vendor within the DLA's pharmaceutical procurement strategy and supporting the agency's planned Pharmaceutical Prime Vendor Global Program Generation V multi-award initiative.
Quick answers
Who was awarded contract SPE2DR26FCM8S?
SPE2DR26FCM8S was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 5, 2025.
How much is contract SPE2DR26FCM8S worth?
The government has obligated $3,869 on SPE2DR26FCM8S.
Is contract SPE2DR26FCM8S an order under another contract?
Yes. SPE2DR26FCM8S is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCM8S competed?
The extent of competition for SPE2DR26FCM8S was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award